Bret  Scholtes net worth and biography

Bret Scholtes Biography and Net Worth

Bret was appointed as President and Chief Executive Officer of Guardion Health Sciences in January of 2021. He is also a member of the company’s Board of Directors. Before joining Guardion, he spent nine years as the President and Chief Executive Officer of Omega Protein Corporation, and he was also a member of the company’s Board of Directors. Prior to becoming CEO, Bret served as Omega Protein’s Chief Financial Officer. Bret was also with General Electric for five years, has held strategy and corporate development positions at two publicly traded companies, and earned five years of public accounting experience at Arthur Andersen & Co. and Price Waterhouse.

What is Bret Scholtes' net worth?

The estimated net worth of Bret Scholtes is at least $11.20 thousand as of August 30th, 2021. Mr. Scholtes owns 3,479 shares of Guardion Health Sciences stock worth more than $11,202 as of December 5th. This net worth approximation does not reflect any other investments that Mr. Scholtes may own. Learn More about Bret Scholtes' net worth.

How do I contact Bret Scholtes?

The corporate mailing address for Mr. Scholtes and other Guardion Health Sciences executives is 15150 AVENUE OF SCIENCE SUITE 200, SAN DIEGO CA, 92128. Guardion Health Sciences can also be reached via phone at (800) 873-5141 and via email at [email protected]. Learn More on Bret Scholtes' contact information.

Has Bret Scholtes been buying or selling shares of Guardion Health Sciences?

Bret Scholtes has not been actively trading shares of Guardion Health Sciences within the last three months. Most recently, on Monday, August 30th, Bret Scholtes bought 90 shares of Guardion Health Sciences stock. The stock was acquired at an average cost of $63.00 per share, with a total value of $5,670.00. Following the completion of the transaction, the chief executive officer now directly owns 3,479 shares of the company's stock, valued at $219,177. Learn More on Bret Scholtes' trading history.

Bret Scholtes Insider Trading History at Guardion Health Sciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/30/2021Buy90$63.00$5,670.003,479View SEC Filing Icon  
See Full Table

Bret Scholtes Buying and Selling Activity at Guardion Health Sciences

This chart shows Bret Scholtes's buying and selling at Guardion Health Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Guardion Health Sciences Company Overview

Guardion Health Sciences logo
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.
Read More

Today's Range

Now: $3.22
Low: $3.22
High: $3.29

50 Day Range

MA: $3.24
Low: $3.22
High: $3.50

2 Week Range

Now: $3.22
Low: $3.04
High: $18.00

Volume

4,700 shs

Average Volume

105,261 shs

Market Capitalization

$4.35 million

P/E Ratio

0.66

Dividend Yield

155.28%

Beta

0.73